Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia

BackgroundLoss of upper extremity function after tetraplegia results in significant disability. Emerging evidence from pilot studies suggests that functional electrical stimulation (FES) therapy may enhance recovery of upper extremity function after tetraplegia. The aim of this trial was to determin...

Full description

Bibliographic Details
Main Authors: Kim D. Anderson, Radha Korupolu, Kristin E. Musselman, Jacqueline Pierce, James R. Wilson, Nuray Yozbatiran, Naaz Desai, Milos R. Popovic, Lehana Thabane
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Rehabilitation Sciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fresc.2022.995244/full
_version_ 1797964759270686720
author Kim D. Anderson
Kim D. Anderson
Radha Korupolu
Radha Korupolu
Kristin E. Musselman
Kristin E. Musselman
Jacqueline Pierce
James R. Wilson
James R. Wilson
Nuray Yozbatiran
Nuray Yozbatiran
Naaz Desai
Milos R. Popovic
Milos R. Popovic
Milos R. Popovic
Lehana Thabane
Lehana Thabane
Lehana Thabane
author_facet Kim D. Anderson
Kim D. Anderson
Radha Korupolu
Radha Korupolu
Kristin E. Musselman
Kristin E. Musselman
Jacqueline Pierce
James R. Wilson
James R. Wilson
Nuray Yozbatiran
Nuray Yozbatiran
Naaz Desai
Milos R. Popovic
Milos R. Popovic
Milos R. Popovic
Lehana Thabane
Lehana Thabane
Lehana Thabane
author_sort Kim D. Anderson
collection DOAJ
description BackgroundLoss of upper extremity function after tetraplegia results in significant disability. Emerging evidence from pilot studies suggests that functional electrical stimulation (FES) therapy may enhance recovery of upper extremity function after tetraplegia. The aim of this trial was to determine the effectiveness of FES therapy delivered by the Myndmove stimulator in people with tetraplegia.MethodsA multi-center, single-blind, parallel-group, two-arm, randomized controlled trial was conducted comparing FES to conventional therapy in adults (≥18 years) with C4–C7 traumatic incomplete tetraplegia between 4 and 96 months post-injury, and with a baseline spinal cord injury independence measure III -self-care (SCIM III-SC) score of ≤10. Participants were enrolled at four SCI-specialized neurorehabilitation centers in the U.S. and Canada. Participants were stratified by center and randomized in a 1:1 ratio to receive either 40 sessions of FES or conventional therapy targeting upper extremities over a 14-week period. Blinded assessors measured SCIM III, Toronto Rehabilitation Institute Hand Function Test, and Graded Redefined Assessment of Strength, Sensibility, and Prehension at baseline, after 20th session, after 40th session or 14 weeks after 1st session, and at 24 weeks after 1st session. The primary outcome measure was change in SCIM III-SC from baseline to end of the treatment. Based on the primary outcome measure, a sample size of 60 was calculated. Seventeen participants' progress in the study was interrupted due to the COVID-19 lockdown. The protocol was modified for these participants to allow them to complete the study.ResultsBetween June 2019 to August 2021, 51 participants were randomized to FES (n = 27) and conventional therapy (n = 24). Both groups gained a mean of 2 points in SCIM-SC scores at the end of treatment, which was a clinically meaningful change. However, there was no statistically significant difference between the groups on any outcomes.ConclusionForty sessions of FES therapy delivered by the MyndMove stimulator are as effective as conventional therapy in producing meaningful functional improvements that persist after therapy is completed. Limitations of this study include the impact of COVID-19 limiting the ability to recruit the target sample size and per-protocol execution of the study in one-third of the participants.RegistrationThis trial is registered at www.ClinicalTrials.gov, NCT03439319.
first_indexed 2024-04-11T01:48:58Z
format Article
id doaj.art-8dee12c38afa4c8d9cb8f33d7ece2376
institution Directory Open Access Journal
issn 2673-6861
language English
last_indexed 2024-04-11T01:48:58Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Rehabilitation Sciences
spelling doaj.art-8dee12c38afa4c8d9cb8f33d7ece23762023-01-03T07:14:12ZengFrontiers Media S.A.Frontiers in Rehabilitation Sciences2673-68612022-09-01310.3389/fresc.2022.995244995244Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegiaKim D. Anderson0Kim D. Anderson1Radha Korupolu2Radha Korupolu3Kristin E. Musselman4Kristin E. Musselman5Jacqueline Pierce6James R. Wilson7James R. Wilson8Nuray Yozbatiran9Nuray Yozbatiran10Naaz Desai11Milos R. Popovic12Milos R. Popovic13Milos R. Popovic14Lehana Thabane15Lehana Thabane16Lehana Thabane17MetroHealth Rehabilitation Institute, MetroHealth System, Cleveland, OH, United StatesDepartment of Physical Medicine and Rehabilitation, Case Western Reserve University School of Medicine, Cleveland, OH, United StatesDepartment of Physical Medicine and Rehabilitation, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United StatesThe Institute of Rehabilitation / Research (TIRR) Memorial Hermann, Houston, TX, United StatesThe KITE Research Institute, University Health Network, Toronto, ON, CanadaDepartment of Physical Therapy, University of Toronto, Toronto, ON, CanadaHealthTech Connex Centre for Neurology Studies/Neuromotion Physiotherapy, Vancouver, BC, CanadaMetroHealth Rehabilitation Institute, MetroHealth System, Cleveland, OH, United StatesDepartment of Physical Medicine and Rehabilitation, Case Western Reserve University School of Medicine, Cleveland, OH, United StatesDepartment of Physical Medicine and Rehabilitation, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United StatesThe Institute of Rehabilitation / Research (TIRR) Memorial Hermann, Houston, TX, United StatesKrembil Research Institute-University Health Network, Toronto, ON, CanadaThe KITE Research Institute, University Health Network, Toronto, ON, CanadaInstitute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada0CRANIA, University Health Network, Toronto, ON, Canada1Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton ON, Canada2Biostatistics Unit, St. Joseph’s Healthcare, Hamilton, ON, Canada3Faculty of Health Sciences, University of Johannesburg, Johannesburg, Gauteng, South AfricaBackgroundLoss of upper extremity function after tetraplegia results in significant disability. Emerging evidence from pilot studies suggests that functional electrical stimulation (FES) therapy may enhance recovery of upper extremity function after tetraplegia. The aim of this trial was to determine the effectiveness of FES therapy delivered by the Myndmove stimulator in people with tetraplegia.MethodsA multi-center, single-blind, parallel-group, two-arm, randomized controlled trial was conducted comparing FES to conventional therapy in adults (≥18 years) with C4–C7 traumatic incomplete tetraplegia between 4 and 96 months post-injury, and with a baseline spinal cord injury independence measure III -self-care (SCIM III-SC) score of ≤10. Participants were enrolled at four SCI-specialized neurorehabilitation centers in the U.S. and Canada. Participants were stratified by center and randomized in a 1:1 ratio to receive either 40 sessions of FES or conventional therapy targeting upper extremities over a 14-week period. Blinded assessors measured SCIM III, Toronto Rehabilitation Institute Hand Function Test, and Graded Redefined Assessment of Strength, Sensibility, and Prehension at baseline, after 20th session, after 40th session or 14 weeks after 1st session, and at 24 weeks after 1st session. The primary outcome measure was change in SCIM III-SC from baseline to end of the treatment. Based on the primary outcome measure, a sample size of 60 was calculated. Seventeen participants' progress in the study was interrupted due to the COVID-19 lockdown. The protocol was modified for these participants to allow them to complete the study.ResultsBetween June 2019 to August 2021, 51 participants were randomized to FES (n = 27) and conventional therapy (n = 24). Both groups gained a mean of 2 points in SCIM-SC scores at the end of treatment, which was a clinically meaningful change. However, there was no statistically significant difference between the groups on any outcomes.ConclusionForty sessions of FES therapy delivered by the MyndMove stimulator are as effective as conventional therapy in producing meaningful functional improvements that persist after therapy is completed. Limitations of this study include the impact of COVID-19 limiting the ability to recruit the target sample size and per-protocol execution of the study in one-third of the participants.RegistrationThis trial is registered at www.ClinicalTrials.gov, NCT03439319.https://www.frontiersin.org/articles/10.3389/fresc.2022.995244/fullfunctional electrical simulation (FES)spinal cord injurytetraplegiatherapyrehabilation
spellingShingle Kim D. Anderson
Kim D. Anderson
Radha Korupolu
Radha Korupolu
Kristin E. Musselman
Kristin E. Musselman
Jacqueline Pierce
James R. Wilson
James R. Wilson
Nuray Yozbatiran
Nuray Yozbatiran
Naaz Desai
Milos R. Popovic
Milos R. Popovic
Milos R. Popovic
Lehana Thabane
Lehana Thabane
Lehana Thabane
Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
Frontiers in Rehabilitation Sciences
functional electrical simulation (FES)
spinal cord injury
tetraplegia
therapy
rehabilation
title Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
title_full Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
title_fullStr Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
title_full_unstemmed Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
title_short Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
title_sort multi center single blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia
topic functional electrical simulation (FES)
spinal cord injury
tetraplegia
therapy
rehabilation
url https://www.frontiersin.org/articles/10.3389/fresc.2022.995244/full
work_keys_str_mv AT kimdanderson multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT kimdanderson multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT radhakorupolu multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT radhakorupolu multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT kristinemusselman multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT kristinemusselman multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT jacquelinepierce multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT jamesrwilson multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT jamesrwilson multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT nurayyozbatiran multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT nurayyozbatiran multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT naazdesai multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT milosrpopovic multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT milosrpopovic multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT milosrpopovic multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT lehanathabane multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT lehanathabane multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia
AT lehanathabane multicentersingleblindrandomizedcontrolledtrialcomparingfunctionalelectricalstimulationtherapytoconventionaltherapyinincompletetetraplegia